Crohn’s & Colitis Foundation Perspectives-logo

Crohn’s & Colitis Foundation Perspectives

ReachMD

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
More Information

Location:

United States

Networks:

ReachMD

Description:

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.

Language:

English


Episodes

What IBD Professionals can Expect from the 2019 Annual Crohn’s & Colitis Congress

9/20/2018
More
The Crohn’s & Colitis Foundation, in partnership with the American Gastroenterological Association, will hold their 2nd Annual Congress from February 7 - 9, 2019 at the Bellagio Hotel in Las Vegas. To give you an inside look into the premier meeting for all IBD professionals and researchers, here’s a special message from Michael Osso, President & CEO of the Crohn’s & Colitis Foundation. For more information and to register, please go to: www.crohnscolitiscongress.org.

Duration:00:00:59

IBD: A Journey from Parent to Advocate

9/20/2018
More
Host: Jennifer Caudle, DO For many IBD patients and their parents, becoming involved with advocacy groups provides an excellent support system, especially since this can be a difficult disease to manage. But some also use these groups to make a difference not only locally, but also nationally. Sharing his personal-turned-professional journey with Dr. Jennifer Caudle is Frank Russomano, President and CEO of ReachMD, who is also joined by the President & CEO of the Crohn’s & Colitis...

Duration:00:08:29

IBD Patient Management: Professional Education at Your Fingertips

9/20/2018
More
Host: Jennifer Caudle, DO With no cure for inflammatory bowel disease, or IBD, currently available, educating healthcare professionals and their patients on the best ways to manage IBD is essential. That’s why the Crohn’s & Colitis Foundation created training programs as part of their mission to eradicate these painful diseases, and here to talk more about these resources and programs with Dr. Jennifer Caudle is Michael Osso, President & CEO of the Crohn’s & Colitis Foundation.

Duration:00:06:29

Highlights from the Crohn’s & Colitis Foundation Perspectives Series

5/23/2018
More
Hear from experts, patients, and caregivers as they discuss the latest in IBD in the Crohn’s & Colitis Foundation Perspectives series.

Duration:00:01:00

A Message from the President & CEO of Crohn’s & Colitis Foundation

5/23/2018
More
Hear from Michael Osso, President and CEO of the Crohn’s & Colitis Foundation, as he talks about the Crohn’s & Colitis Foundation Perspectives series on ReachMD.

Duration:00:00:30

IBD Expert Panel: When is the Right Time to Refer to GI?

4/12/2018
More
Host: Brian P. McDonough, MD, FAAFP Guest: John D. Betteridge, MD Guest: Philip Stein, MD Guest: Thomas Judge, M.D. From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough moderates an expert gastroenterology panel exploring some of the top issues in IBD management: the best time for primary care clinicians to refer patients to GI, challenges to making an early diagnosis, and differences between IBD and IBS. Panel participants include: Dr. John Betteridge,...

Duration:00:20:59

The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective

4/12/2018
More
Host: Philip Stein, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Claire Griffin and Bill Johnson, patients and counselors at CCF's Camp Oasis. Claire and Bill discuss their respective involvements with the camp, why they made the decision to go, how they became their own personal advocates, and what Camp Oasis taught them about adjusting to their disease.

Duration:00:09:29

The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective

4/12/2018
More
Host: Philip Stein, MD Guest: Neilanjan Nandi, MD, FACP Guest: Susan Peck, MSN, CRNP From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Dr. Neilanjan Nandi and nurse practitioner Susan Peck about their respective experiences with The Crohn’s & Colitis Foundation's Camp Oasis. This camp gives children with IBD the opportunity to meet other kids with the same chronic illness, teaching them how to cope with their disease, manage their own...

Duration:00:09:29

Travel for IBD Patients: How to Help Them Prepare

4/12/2018
More
Host: Adam Ehrlich, MD, MPH Guest: Adam Kaufman, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Adam C. Ehrlich talks with Dr. Adam Kaufman, Gastroenterologist at Main Line Gastroenterology Associates. Dr. Kaufman brings to the forefront the importance of preparing your IBD patient for travel. Discussion points include scheduling a pre-travel counsel visit, medication choices and proper storage procedures, vaccination considerations, blood clot prophylaxis, and...

Duration:00:10:29

IBD and Intimacy: Managing an Under-Recognized Issue

4/12/2018
More
Host: Robert Frankel, MD Guest: Neilanjan Nandi, MD, FACP From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Robert Frankel talks with Dr. Neilanjan Nandi, Assistant Professor in the Division of Gastroenterology & Hepatology and Associate Director of the Gastroenterology Fellowship program at Drexel University College of Medicine. Dr. Nandi shares new insights on how to approach sexual and intimacy issues for IBD patients. Discussion points include quality of life...

Duration:00:11:59

IBD Preventive Care: Clinical Priorities for Best Patient Outcomes

4/12/2018
More
Host: Brian P. McDonough, MD, FAAFP Guest: Adam Ehrlich, MD, MPH Guest: John D. Betteridge, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough leads an expert panel focusing on preventive care for IBD patients. Joining the expert panel are: Dr. Adam C. Ehrlich, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Co-Medical Director of the Temple Inflammatory Bowel Disease Program, and Dr. John D. Betteridge,...

Duration:00:14:59

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

1/2/2018
More
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance. Liefferinckx C1, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, Franchimont D. BACKGROUND: Infliximab (IFX) is indicated for the treatment of inflammatory bowel diseases (IBD). Nevertheless, loss of response (LOR) to IFX is reported in up to 10% to 30% of patients within the first year of treatment. Our objective was to evaluate the impact of the...

Duration:00:04:29

RISK Cohort Study in Crohn's Disease

12/15/2017
More
From the 42nd Annual Renaissance Ball in Philadelphia benefiting the Crohn's & Colitis Foundation, host Lu Ann Cahn talks with Dr. David Piccoli, Chief of the Division of Gastroenterology, Hepatology and Nutrition, Director of the Biesecker PediatricLiver Center, and a board-certified pediatric gastroenterologist at Children's Hospital of Philadelphia. Dr. Piccoli discusses the RISK study, supported by the Crohn’s & Colitis Foundation, and the challenges patients face with response...

Duration:00:09:29

Improving Care for Children with IBD

12/15/2017
More
From the 42nd Annual Renaissance Ball in Philadelphia benefiting the Crohn's & Colitis Foundation, host Lu Ann Cahn talks with Dr. Jose Fernando Del Rosario, head of Pediatric Gastroenterology at the Nemours Alfred I. duPont Hospital for Children in Wilmington, DE. Dr. Del Rosario and his department are the recipients of this year’s Gold Medallion Award from the Foundation. He discusses providing a positive experience for the patient and the importance of teaching children how to...

Duration:00:04:29

Managing IBD: A Patient's Perspective

12/15/2017
More
From the 42nd Annual Renaissance Ball in Philadelphia benefiting the Crohn's & Colitis Foundation, host Lu Ann Cahn talks with Michael and Ellen Araten, recipients of the Founders Award for the Philadelphia Chapter. The Aratens have been involved with the Foundation for over 20 years and discuss how the organization has assisted Ellen and her family upon her diagnosis. Ellen offers her perspective as a patient and the struggles she has overcome with the support of the organization.

Duration:00:04:59

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

10/30/2017
More
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Vavricka SR1, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N, Juillerat P, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Heinrich H, Manser CN, Safroneeva E, Raja Ali RA, Rogler G, Schoepfer AM, Greuter T; Swiss IBD Cohort Study Group. BACKGROUND: Extraintestinal manifestations (EIMs) in patients with inflammatory bowel...

Duration:00:06:29

Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure

7/28/2017
More
Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure Assa A1, Bronsky J, Kolho KL, Zarubova K, de Meij T, Ledder O, Sladek M, van Biervliet S, Strisciuglio C, Shamir R. BACKGROUND: The outcome of patients with Crohn's disease who failed anti-tumor necrosis factor alpha (anti-TNFα) therapy despite adequate serum drug levels (pharmacodynamic failure) is unclear. We aimed to assess such pediatric patients who underwent intestinal...

Duration:00:05:59

Gut Feeling: The Links Between IBD and Mental Health

7/7/2017
More
Host: Adam Ehrlich, MD, MPH Guest: Alison Kaufman, PsyD Our body responds to stress and anxiety in a variety of ways. For patients with IBD, the body manifests stress into various psychological issues, creating a link between IBD and mental health. Dr. Alison Kaufman, a psychologist at Children’s Hospital of Philadelphia will discuss the common emotional reactions of IBD patients, suggesting ways for physicians to help these patients cope with their chronic disease. She is joined by Dr....

Duration:00:07:59

Growing Up With IBD: When to Transition to an Adult GI Specialist

7/7/2017
More
Host: Adam Ehrlich, MD, MPH Guest: Philip Stein, MD The majority of adolescents with inflammatory bowel disease (IBD) will transition from a pediatric to an adult specialist. This process can be daunting, especially if patients are not ready to take control of their health care. However, with the right communication and preparation, the transition can be smooth for the patient, parent, and physician. Host Dr. Adam Ehrlich joins Dr. Philip Stein, a pediatric gastroenterologist at St....

Duration:00:06:29

The Latest Treatment Options for IBD Patients

7/7/2017
More
Host: Rebecca Kaplan Guest: Adam Ehrlich, MD, MPH As new treatment options become available for IBD patients, it is important to be informed on which treatments will work best for which patient populations. Dr. Adam Ehrlich, Assistant Professor of Medicine at Temple University School of Medicine, joins Rebecca Kaplan to discuss what's coming down the drug pipeline for patients with IBD. He will touch on the recent medication approvals of biologics and biosimilars, as well as how IBD...

Duration:00:05:59